PRIVISCL Privi Speciality Chemicals Q4 FY25 results (Jan–Mar 2025) and concall
Privi Speciality Chemicals reported its best-ever quarterly and annual financial performance for Q4 and FY25, driven by strong demand, optimal plant operations, and strategic initiatives like debottlenecking and new product launches. The company achieved record revenues and significant margin expansion, with management expressing confidence in sustaining growth and profitability through operational efficiencies and market diversification. The new PRIGIV JV commenced operations, with break-even expected in FY27.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 518 | 498 | 581 |
| EBITDA | 111 | 111 | 127 |
| Net profit | 47 | 44 | 66 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
